[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-astellas":3},{"head":4,"company":39,"invest":44,"children":45,"shops":46,"category":47,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":13,"brandBirth":14,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":15,"status":16,"isDeleted":16,"comment":5,"remark":5,"logoExistStatus":17,"imageExistStatus":17,"industryId":5,"industryRanking":5,"score":5,"enterName":18,"mallShopList":19,"brandSummary":5,"likes":5,"unlikes":5,"follow":5,"pagetitle":20,"pagekeywords":21,"pagedesc":22,"brandContent":23,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":33,"businessscope":34,"ownBrand":5,"enterTelphone":35,"enterWebsite":36,"business":37,"enterQq":5,"enterMail":38,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"134265","\u002Fprofile\u002Fupload\u002F2023\u002F12\u002F02\u002F567d187333d3b766d8f43056f7fdb022.gif","Astellas安斯泰来","astellas",135144,5593,"400-085-6799","1923年","日本",282,0,"1","安斯泰来制药（中国）有限公司",[],"Astellas安斯泰来简介-安斯泰来药物-品牌之家","Astellas安斯泰来品牌介绍,安斯泰来药物好不好,安斯泰来怎么样,安斯泰来,安斯泰来制药(中国)有限公司","Astellas安斯泰来品牌简介，品牌之家为你介绍安斯泰来制药(中国)有限公司旗下Astellas安斯泰来品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你安斯泰来药物怎么样，致力于帮助你了解Astellas安斯泰来真实有效的品牌相关信息。","成立于1923年，全球知名的大型跨国制药企业，主要从事肿瘤及专科治疗等创新型医药产品的研发、生产和销售，于1994年进入中国市场，致力于为人们提供高质量的创新药品和服务\n\n安斯泰来制药集团是一家跨国制药企业，在全球范围内研发、生产及销售创新型医药产品，业务遍及全球70多个国家和地区。安斯泰来（Astellas）名称来源于希腊、拉丁及英文中有关“星辰” 的词汇，寓意“大志之星”、“先进之星”，同时与日语中“照亮明天”发音近似。公司名称体现了专注研发、以创新及可靠的药物为全人类带来更美好明天的承诺。\n\n截止2021年3月31日，安斯泰来制药集团全球员工约为15000人。安斯泰来制药集团正推进“焦点领域的研究策略”，旨在通过聚焦生理机制和治疗手段，确定持续研发新药的机会，解决尚未被满足的医疗需求。与此同时，安斯泰来制药集团正将目光投向处方药以外的业务领域，将专业技能和知识与不同领域外部合作伙伴的技术相结合，打造Rx+®医疗解决方案。通过这些努力，安斯泰来立志处于不断变化的医疗行业的前沿，将科学创新转变为对患者的价值。\n\n安斯泰来中国是安斯泰来制药集团在中国设立的全资公司，由安斯泰来（中国）投资有限公司（简称安斯泰来投资）、北京安斯泰来医药有限公司（简称北京安斯泰来医药）及安斯泰来制药（中国）有限公司（简称安斯泰来制药）组成。安斯泰来投资作为大中华商业区的区域总部，全资控股北京安斯泰来医药及安斯泰来制药。后两者分别为安斯泰来在中国市场的肿瘤及专科治疗产品营销中心以及药品生产制造中心。\n\n安斯泰来于1994年进入中国，在中国市场销售的产品涉及肿瘤、移植免疫、泌尿等等多个专业治疗领域。截止2021年底，安斯泰来中国员工约为1000人。中国是安斯泰来全球增长战略中至关重要的一部分。安斯泰来始终专注于尚未满足的医疗需求，以公开、诚信和协作的方式开展业务，全心全意向中国大众提供高质量的创新药品和服务，提升中国社会的健康福祉，助力健康中国2030的目标早日实现。","沈阳经济技术开发区10号路6甲3号","912101066046138951","有限责任公司(外国法人独资)","高玉平","1994-10-14","沈阳市铁西区市场监督管理局","-","2025-02-13","3,526.3336万(美元)","3,526万(美元)","一、医药品的制造、销售、开发及咨询；二、医疗器械的咨询；三、其他保健品和卫生材料的制造、销售。四、为安斯泰来集团提供与医药品质量评价相关的技术业务服务。※（依法须经批准的项目，经相关部门批准后方可开展经营活动。）","024-25814488","www.astellas.com.cn","医药制造业","wanying.liu@astellas.com",{"enterId":40,"enterName":18,"province":5,"city":5,"area":5,"detailaddress":24,"unifiedscc":25,"enterType":26,"enterLegalperson":27,"enterStablishdate":28,"regauthority":29,"licenseValidity":30,"approvaldate":31,"regcapital":32,"incapital":33,"businessscope":34,"ownBrand":5,"enterTelphone":35,"enterWebsite":36,"business":37,"performance":41,"socialSecurity":42,"registrationNumber":43,"enterQq":5,"enterMail":38,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":16,"regtrademark":5,"remark":5},"135144","开业","143人","210100401001799",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[48,67],{"createTime":49,"updateTime":50,"createBy":5,"updateBy":5,"industryId":51,"webId":5,"industryName":52,"industryAlias":53,"industryIcon":5,"industryTrans":54,"pageTitle":55,"pageDesc":56,"pageKeywords":57,"mainTitle":58,"pageSubtitle":59,"indSummary":60,"industryLevel":61,"parentId":62,"parentName":63,"sortOrder":64,"status":16,"classifyVisit":65,"totalVisits":66,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-14 16:50:00","5593","药品","药品,药物,医药制剂,医疗药品,医用药品,药片","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F175454c1767ce2414a13f8c3c16194de.png","十大药品品牌-药品十大厂家-ZGALL品牌榜","2026年药品行业十大品牌权威发布！药品排行榜前十名品牌有三九、同仁堂、广药白云山、云南白药、太极药业、修正、念慈菴、天士力、扬子江药业、仁和。药品10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解药品哪个牌子好。","药品十大品牌排名,OTC药品十大品牌,非处方药品牌十大排行榜,OTC药品排行,药品品牌有哪些","药品品牌排行榜","2026药品品牌排行榜，OTC药品排行，OTC常用药品有哪些","药品什么牌子好？品牌TOP榜权威发布2026年药品十大品牌名录；居前十的有：三九999、同仁堂、广药白云山、云南白药、太极药业TAIJI、修正、京都念慈菴、天士力TASLY、扬子江药业、仁和药业RenHe等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,"医药用品",20,12,1057,{"createTime":49,"updateTime":68,"createBy":69,"updateBy":5,"industryId":70,"webId":5,"industryName":71,"industryAlias":72,"industryIcon":5,"industryTrans":73,"pageTitle":74,"pageDesc":75,"pageKeywords":76,"mainTitle":77,"pageSubtitle":78,"indSummary":79,"industryLevel":61,"parentId":80,"parentName":81,"sortOrder":61,"status":16,"classifyVisit":5,"totalVisits":82,"searchName":5,"starLevel":5,"limit":5},"2026-06-12 21:24:00","admin","6264","世界药企","世界药企,世界药业,世界制药公司,制药企业,跨国药企,顶级药企,国际制药企业","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002Fef709dae5b8900ecf67b93cdeb6e8c7c.png","世界药企十大排行榜-世界十大制药公司有哪些-ZGALL品牌榜","2026年世界药企十大排行榜最新发布，世界药企排行榜前十名有辉瑞、诺华、罗氏、艾伯维、强生、默沙东、百时美施贵宝、赛诺菲、葛兰素史克、阿斯利康。世界药企10大排行榜由品牌研究部门收集整理大数据分析研究得出，帮助你了解世界药企业排名前十名。","世界制药公司排行,世界医药企业排名前十,世界医药公司排名前十,世界医药公司排行榜,国际制药公司排行","世界药企品牌排行榜","2026世界制药企业榜中榜，全球药企TOP10，国际制药企业十强","世界药企什么牌子好？品牌TOP榜权威发布2026年世界药企十大品牌名录；居前十的有：pfizer辉瑞、NOVARTIS诺华、Roche、abbvie艾伯维、Johnson强生、MSD默沙东、BMS百时美施贵宝、Sanofi赛诺菲、GSK葛兰素史克、Astrazeneca阿斯利康等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",68,"医疗\u002F护理",97825]